Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7M Buy
8,255
+1,962
+31% +$672K 0.24% 67
2026
Q1
$14.9M Buy
6,293
+743
+13% +$265K 0.21% 76
2025
Q4
$12.2M Buy
5,550
+515
+10% +$163K 0.15% 110
2025
Q3
$10.3M Buy
5,035
+603
+14% +$175K 0.15% 93
2025
Q2
$9.11M Buy
4,432
+2,152
+94% +$610K 0.13% 92
2025
Q1
$3.12M Sell
2,280
-367
-14% -$108K 0.06% 140
2024
Q4
$694K Buy
+2,647
New +$785K 0.01% 306

Other funds holding AMGN

Union Bancaire Privee's AMGN Position: Q2 2026 in Review

Union Bancaire Privee increased its Amgen (AMGN) stake by 31% in Q2 2026, buying an estimated $672K and bringing the position to 8,255 shares worth $21.7M. The position accounts for 0.24% of the portfolio, ranked #67.

Union Bancaire Privee first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,261 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Union Bancaire Privee held 8,255 shares of Amgen worth $21.7M as of Q2 2026.
  • Union Bancaire Privee bought 1,962 Amgen shares in Q2 2026, an estimated $672K.
  • Amgen made up 0.24% of Union Bancaire Privee's portfolio in Q2 2026, its #67 holding.
  • Union Bancaire Privee first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,261 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.